Related Experiment Video
Updated: Jun 2, 2026

08:17
Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major
Published on: October 28, 2022
Acute phase protein response in experimental canine leishmaniasis
Silvia Martinez-Subiela1, Dalit Strauss-Ayali, Jose J Cerón
1Animal Medicine and Surgery Department, Veterinary School, University of Murcia, 30100 Espinardo, Murcia, Spain. silviams@um.es
Veterinary Parasitology
|April 23, 2011
Summary
Acute phase proteins (APPs) show promise as early diagnostic markers for canine leishmaniasis. Monitoring APP levels can also effectively track treatment response in infected dogs.
Area of Science:
- Veterinary Medicine
- Immunology
- Parasitology
Background:
- Acute phase proteins (APPs) are potential biomarkers for canine leishmaniasis.
- The dynamic changes (kinetics) of APPs during infection and treatment are not well understood.
Purpose of the Study:
- To investigate the kinetics of APPs in dogs experimentally infected with Leishmania infantum.
- To evaluate APPs as markers for disease diagnosis and treatment monitoring.
Main Methods:
- Monitoring serum haptoglobin, serum amyloid A, and C-reactive protein in infected dogs over 21 months.
- Assessing immunoglobulin G (IgG) and M (IgM) levels.
- Dogs were treated with allopurinol after initial infection.
Main Results:
- Experimental Leishmania infantum infection significantly increased all studied APPs by 2 months post-infection.
- Clinical recovery correlated with a significant decrease in APPs one month after treatment initiation.
- Immunoglobulin increases were delayed compared to APPs, and they did not decrease significantly with treatment.
Conclusions:
- APPs can serve as early indicators for canine leishmaniasis.
- APP levels are valuable for monitoring therapeutic effectiveness in canine leishmaniasis.
Related Concept Videos
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
